MedTrace Logo

Genetic Modifiers of Cystic Fibrosis: Sibling Study

NCT00037778 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3459

Last updated 2016-08-31

No results posted yet for this study

Summary

The purpose of this study is to identify modifier genes in cystic fibrosis (CF).

Conditions

Sponsors & Collaborators

Principal Investigators

  • Garry Cutting · Johns Hopkins University

Eligibility

Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-09-30
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00037778 on ClinicalTrials.gov